Journal article icon

Journal article

A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT

Abstract:
Background Tranexamic acid reduces blood loss in surgery and the risk of death in trauma patients. Meta-analyses of small trials suggest that tranexamic acid decreases the number of deaths from gastrointestinal bleeding, but these meta-analyses are prone to selection bias.
Objective The trial provides reliable evidence of the effect of tranexamic acid on mortality, rebleeding and complications in significant acute gastrointestinal bleeding.
Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3310/hta25580

Authors

More by this author
Role:
Author
ORCID:
0000-0003-1596-6054
More by this author
Role:
Author
ORCID:
0000-0002-6511-109X
More by this author
Role:
Author
ORCID:
0000-0002-6195-6669
More by this author
Role:
Author
ORCID:
0000-0002-9596-3998
More by this author
Role:
Author
ORCID:
0000-0002-1405-9391


Publisher:
NIHR Journals Library
Journal:
Health Technology Assessment More from this journal
Volume:
25
Issue:
58
Publication date:
2021-10-19
DOI:
EISSN:
2046-4924
ISSN:
1366-5278
Pmid:
34663491


Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP